Families Hit Back At GSK'S Zofran Fraud Dismissal Bid
Plaintiffs in a multidistrict litigation against GlaxoSmithKline PLC told a Massachusetts federal court Tuesday that they adequately set out off-label fraud claims in master complaints linking the anti-nausea drug Zofran to...To view the full article, register now.
Already a subscriber? Click here to view full article